Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, April 17, 2002

Lack of Awareness of Acute Stroke Symptoms and Treatment Options Contributes to Underutilization of Important Therapy

Denver, Colo. -

Important thrombolytic, or clot-busting, treatment for acute stroke victims may be underutilized due to poor recognition of stroke symptoms and inadequate knowledge of acute treatment options. This conclusion emphasizes the need for more structured stroke education and prevention programs for persons at high risk, according to a study presented at the 54th Annual Meeting of the American Academy of Neurology. Researchers from Mayo Clinic in Rochester, Minn., mailed a written survey to 1,086 randomly selected people in Olmsted County, Minn., and received 364 completed surveys. The survey assessed knowledge of overall definition of stroke, stroke risk factors, symptoms, treatment, and potential for prevention, along with prior medical history, attitudes towards health care, and other factors. Less than half of respondents could correctly define a stroke. While nearly all survey respondents recognized paralysis as a symptom of stroke, several other symptoms, such as the inability to articulate thoughts into words, visual loss, and numbness or tingling were far less commonly recognized. "We were surprised to find virtually no difference in knowledge of symptoms or treatment between those with stroke risk factors and those without," said study author Kelly Flemming, MD. Nearly two-thirds of respondents did not know about treatment options, or about the urgency of administering therapy, and less than half would call 911 if they thought they were having a stroke. Many respondents recorded that they did not think there was any treatment for stroke. According to study co-author Robert D. Brown, Jr., MD, MPH, the study results suggest a lack of knowledge about many of the key issues regarding stroke, and those at highest risk have some of the lowest levels of understanding. Dr. Brown said, "All health care providers can take this information to heart and improve our stroke education programs in the community. This includes stroke prevention, presenting symptoms, treatment options, and what to do if symptoms occur." "Thrombolytic therapy can be critical to the subsequent quality of life for stroke victims," noted Dr. Flemming, "and while stroke prevention education may be most helpful overall, education about the urgency of stroke treatment is perhaps most important in the event of a stroke." The clot-busting drug treatment must be given within three hours after onset of a stroke. Flemming and colleagues therefore recommend more structured education about stroke prevention techniques, stroke symptoms, and the implications of seeking medical attention at the first sign of stroke among those who are identified as being at high risk for stroke.

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life®, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.

DISCOVER MORE


Subscribe to our email newsletter

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 44,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, LinkedIn, Instagram and YouTube.

Editor's Notes: Robert Brown, MD, will present the research on behalf of lead author, Kelly Flemming, MD, during a poster presentation on Wednesday, April 17, 2002 at 3:00 p.m. in Exhibit Hall C of the Colorado Convention Center. He will be available to answer media questions at a briefing on Monday, April 15, 2002 at 2:00 p.m. in the AAN Press Room (Lobby C, Room 208) of the Convention Center.

For More Information*

Email media@aan.com

*While content of the American Academy of Neurology (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver website, Brain & Life®.